PPP1R1B Antibody

Code CSB-PA002075
Size US$167 How to order?
  • Western Blot analysis of COLO205 cells using DARPP-32 Polyclonal Antibody
  • Western Blot analysis of various cells using DARPP-32 Polyclonal Antibody
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No. Q9UD71
Target Names PPP1R1B
Alternative Names DARPP 32 antibody; DARPP-32 antibody; Dopamine and cAMP regulated neuronal phosphoprotein 32 antibody; Dopamine and cAMP regulated neuronal phosphoprotein antibody; Dopamine and cAMP regulated phosphoprotein antibody; Dopamine and cAMP regulated phosphoprotein DARPP 32 antibody; Dopamine and cAMP regulated phosphoprotein DARPP32 antibody; Dopamine- and cAMP-regulated neuronal phosphoprotein antibody; FLJ20940 antibody; IPPD antibody; Neuronal phosphoprotein DARPP 32 antibody; PPP1R1B antibody; PPR1B_HUMAN antibody; Protein phosphatase 1 regulatory (inhibitor) subunit 1B antibody; Protein phosphatase 1 regulatory inhibitor subunit 1B antibody; Protein phosphatase 1 regulatory subunit 1B antibody
Raised in Rabbit
Species Reactivity Human,Mouse,Rat
Immunogen Synthesized peptide derived from Human DARPP-32 around the non-phosphorylation site of T75.
Immunogen Species Homo sapiens (Human)
Conjugate Non-conjugated
Isotype IgG
Purification Method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration It differs from different batches. Please contact us to confirm it.
Buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Form Liquid
Tested Applications WB, IHC, ELISA
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:40000
Protocols Western Blotting(WB) Protocol
Immunohistochemistry (IHC) Protocol
ELISA Protocol
Troubleshooting and FAQs Antibody FAQs
Storage Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Inhibitor of protein-phosphatase 1.
Gene References into Functions
  1. t-Darpp phosphorylation at T39 seems to be crucial for t-Darpp-mediated PKA activation and this activation appears to occur through an association with RI and sequestering of RI away from PKAc. The t-Darpp-RI interaction could be a druggable target to reduce PKA activity in drug-resistant cancer. PMID: 28867659
  2. our results lend support for a potential role of DARPP-32 genetic variants in neural response to potential reward triggering cues PMID: 29048604
  3. To facilitate live-cell identification, a human embryonic stem cell line was generated using CRISPR-mediated gene editing at the DARPP32 locus. PMID: 28065797
  4. Study associates polymorphisms in DRD2, DARPP-32, and COMT genes with novel category learning performance. Modeling results suggest that striatal dopaminergic genes influence selective attention processes whereas cortical genes mediate the ability to update complex rule representations. PMID: 26918585
  5. Results show that expression of human DARPP-32 protein isoforms depends on the striatal neurodevelopmental stage with t-DARPP being specific for the human adult striatum. PMID: 27475250
  6. In vivo xenograft models demonstrated that overexpression of DARPP-32 promotes angiogenesis and tumour growth. PMID: 25779598
  7. This study strongly suggests that inflammation-regulated DARPP-32 constitutes a key component of H. pylori-mediated gastric tumourigenesis. PMID: 27590997
  8. This study did not find any statistical difference in the state-anxiety dimension for the rs12601930C/T, rs879606A/G, and rs3764352A/G genotypes, but statistical differences in the trait-anxiety dimension for the rs879606A/G (F = 5.207, P = 0.006) and rs3764352A/G (F = 3.960, P = 0.020) genotype. PMID: 27995567
  9. DARPP-32 is mainly cleaved at Thr(153) by calpain and this cleavage of DARPP-32 reduces CREB phosphorylation via loss of its inhibitory function on PP1; results suggest a novel mechanism of DARPP-32-CREB signalling dysregulation in Alzheimer's disease PMID: 26178297
  10. No significant differences in mRNA expression levels of DRD2 and DARPP-32 were found among controls, patients with psychotic disorder not otherwise specified, and schizophrenia/schizophreniform disorder. PMID: 26561806
  11. Striatal function was indexed by a gene coding for DARPP-32, which is densely expressed in the striatum where it is necessary for synaptic plasticity PMID: 26818509
  12. Findings show that PPP1R1B-STARD3 fusion transcript has a key role in subsets of gastric cancers through the activation of PI3K/AKT signaling. PMID: 24276243
  13. The results of this study found that the mean t-DARPP expression level in the caudate was higher in patients with schizophrenia than in control individuals. PMID: 24704945
  14. Results suggest that variation in PPP1R1B affects the abundance of the splice variant t-DARPP-32 mRNA and may reflect potential molecular mechanisms implicated in schizophrenia and affective disorders PMID: 23295814
  15. The immunostaining was more decreased for DARPP-32 than for the morphological changes of striatal neurons in multiple system atrophy. PMID: 23715974
  16. This study showed that variations in genotypes relevant for DARPP-32 functions are associated more with aging-related impairments in the explicit than the implicit component of sequence learning. PMID: 24035787
  17. density of DARPP-32-immunoreactive (IR) neurons in the II and III layers of the RAIC was significantly decreased (p<0.05) in the schizophrenia group compared with the healthy control group. PMID: 21821092
  18. Bcl-2 and DARPP-32 have roles in regulating inositol 1,4,5-trisphosphate receptor phosphorylation and promoting cell survival PMID: 24395794
  19. High DARPP32/STAT3, DARPP32/STAT5B, and STAT5B/STAT3 ratios were associated with longer patient progression free survival. PMID: 23250732
  20. The present study provides novel evidence for an association between the DARPP-32 gene (SNP rs907094) and attentional control of auditory perception. PMID: 23639477
  21. Findings show a novel mechanism by which DARPP-32 promotes cell invasion by regulating CXCR4-mediated activation of the MT1-MMP/MMP-2 pathway. PMID: 23160836
  22. PPP1R1B rs12601930 was associated with projection and splitting. rs3764352 was associated with splitting. No significant association was found between rs879606 and defenses. PPP1R1B polymorphisms are involved in immature defenses. PMID: 23080070
  23. Our findings support a role for the DRD2 and PPP1R1B genes in conferring risk for autism in families with only affected males and show an additive effect of these genes towards prediction of affected status in our families. PMID: 22559203
  24. Our findings uncover a novel mechanism of TRAIL resistance mediated by DARPP-32, whereby it inhibits the intrinsic apoptosis pathway through upregulation of BCL-xL PMID: 22589394
  25. DARPP32 has a role in pluripotent stem cell differentiation toward medium-sized spiny neurons PMID: 23250204
  26. no significant association of BDNF or DARPP-32 polymorphisms with schizophrenia in Malays. PMID: 22576830
  27. the decrease in DARPP-32 in schizophrenia was more marked in neurons of dorsolateral prefrontal cortex than in other cells or other brain regions PMID: 22179181
  28. DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. PMID: 21741919
  29. [review] Genetic polymorphisms modulating DARPP-32 mRNA expression and cognition in humans are associated with changes in activation in the entire striatum, and striatal connectivity with frontal cortex, without connection to any other brain region. PMID: 20631684
  30. the DARPP-32-related pathogenesis in schizophrenia may be more severe in the superior temporal gyrus than previously found in the prefrontal cortex PMID: 21453742
  31. Results suggest that polymorphisms in the DARPP-32 gene are involved in the biological mechanisms that confer the traits of novelty seeking and harm avoidance. PMID: 21369787
  32. Findings demonstrate that t-DARPP regulates beta-catenin/TCF activity, thereby implicating a novel oncogenic signaling in upper gastrointestinal cancers. PMID: 21447180
  33. our data suggest: (i) C14ORF28, GNB2L1, MLLT3, DRD2 and DARPP-32 are important in the pathogenesis of schizophrenia and bipolar disorder PMID: 20874815
  34. Findings underscore the potential role of t-DARPP in regulating cell growth and proliferation through PI3 kinase-dependent mechanism. PMID: 20836878
  35. This study did not find DAOA significant associations with schizophrenia. Thus, PPP1R1B genes do not fit the antagonistic pleiotropy PMID: 20483474
  36. The composite expression score, calculated from immunostaining patterns, increased significantly from normal or gastritis to metaplasia, dysplasia, and adenocarcinoma (P < .001). PMID: 20580047
  37. DARPP-32 changes the usage of tra2-beta1 dependent alternative exons in a concentration-dependent manner, suggesting that the DARPP-32:tra2-beta1 interaction is a molecular link between signaling pathways and pre-mRNA processing. PMID: 20074680
  38. t-Darpp and DARPP-32 expression are novel prognostic and predictive biomarkers in breast cancer. PMID: 19301121
  39. DARPP 32 frequently are overexpressed in common subtypes of human adenocarcinomas suggest that these proteins may be important in tumorigenesis. PMID: 14508844
  40. overexpression of DARPP-32 is associated with gastric cancer PMID: 14991576
  41. DARPP-32 expression arises after a phase of dysplasia esophageal squamous cell carcinoma; tumours expressing DARPP-32 progress less rapidly than DARPP-32-negative tumours PMID: 15188007
  42. multiple domains in I-1 target cellular PP1 complexes, and I-1 has a role as a cellular regulator of eIF2alpha phosphorylation PMID: 15345721
  43. Expression of Darpp-32 is associated with a potent antiapoptotic advantage for cancer cells through a p53-independent mechanism that involves preservation of mitochondrial potential and increased Bcl2 levels. PMID: 16061638
  44. Thus, DARPP-32 signaling downstream of DDR1 is a potential new target for effective anti-metastatic breast cancer therapy PMID: 17027969
  45. Potential involvement of PPP1R1B in the etiology of nicotine dependence. PMID: 17171661
  46. DARPP-32 plays a pivotal role in cognitive function and possibly in the pathogenesis of schizophrenia. PMID: 17290303
  47. The up-regulation of ZNRD1 significantly inhibited the drug sensitivity of gastric cancer cells over-expressing DARPP-32, indicating that ZNRD1 may be important in the DARPP-32-mediated MDR of gastric cancer PMID: 17492506
  48. The present study suggests that DARPP-32 decreases in the DLPFC of patients with schizophrenia and bipolar disorder. PMID: 17521792
  49. The results of this study do not preclude the possibility that the PPP1R1B is a susceptibility gene for schizophrenia in the Chinese population. PMID: 17618027
  50. The decreased expression of DARPP-32 in oral premalignant and malignant lesions suggests a tumor suppressor role for this protein in the tumorigenesis of these lesions. PMID: 17695523

Show More

Hide All

Subcellular Location Cytoplasm.
Protein Families Protein phosphatase inhibitor 1 family
Database Links

HGNC: 9287

OMIM: 604399

KEGG: hsa:84152

STRING: 9606.ENSP00000254079

UniGene: Hs.286192

Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
7505 Fannin St. Ste 610-312, Houston, TX 77054, USA
Join Us with

Subscribe newsletter

Leave a message

© 2007-2022 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1